Citations

Showing 10 of 108162 citations.

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer
Tang, Bo , Wang, Dejie , Sheng, Haoyue , Wei, Ting , Wang, Liguo , Zhang, Jun , Ho, Thai H. , Yang, Lu , Wei, Qiang , Wei, Ting , Sun, Rui , Wang, Dejie , Wei, Ting , Wang, Liguo , Ho, Thai , Wei, Ting , Sun, Rui , Huang, Haojie , Sun, Rui

Mayo Clinic

Proceedings of the National Academy of Sciences | February 16, 2021 | Volume: 118 | Issue: 8 | Pages: No page available

10.1073/pnas.2019052118 | PMID 33593912 Get It

Significance The multiple-domain protein ZMYND8 is well known as a chromatin reader that recognizes methylated, acetylated, and/or mutated histones. Here we report that ZMYND8 is overexpressed in human ccRCC, and that it preferentially binds T487-phosphorylated EZH2. We show that in hypoxia-stimulated or von Hippel–Lindau–deficient cells, ZMYND8 binding of EZH2 is important for maintenance of EZH2 phosphorylation level, inhibition of PRC2 complex formation, and enhanced interaction between EZH2 and FOXM1. Our results reveal a reader function of ZMYND8 in recognizing a phosphorylation “code” on a nonhistone protein. Our findings also identify ZMYND8 binding as a facet of regulation and function of EZH2 phosphorylation in the Polycomb-dependent to -independent switch of EZH2/PRC2 activities.
Biomechanical Analysis of the Sensitivity of Brain Tissue Responses to FE Head Models in the Study of Impact-Induced TBI
Moghaddam, Hesam S., Rezaei, Asghar, Ziejewski, Mariusz, Karami, G.

Mayo Clinic

Volume 5: Biomedical and Biotechnology | February 16, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/imece2020-23086 Get It

Abstract A numerical investigation is conducted on the injury-related biomechanical parameters of the human head under blunt impacts. The objective of this research is twofold; first to understand the role of the employed finite element (FE) head model — with its specific components, shape, size, material properties, and mesh size — in predicting tissue responses of the brain, and second to investigate the fidelity of pressure response in validating FE head models. Accordingly, two independently established and validated FE head models are impacted in two directions under two impact severities and their predicted responses in terms of intracranial pressure (ICP) and shear stress are compared. The coup-counter ICP peak values are less sensitive to head model, mesh size, and the brain material. In all cases, maximum ICPs occur on the outer surface, vanishing linearly toward the center of the brain. Hence, it is concluded that different head models may simply reproduce the results of ICP variations due to impact. Shear stress prediction, however, is mainly affected by the head model, direction and severity of impact, and the brain material.
Growth of Unruptured Aneurysms: A Meta-analysis of Natural History and Endovascular Studies
Doormaal, Pieter Jan van , Es, Adriaan C.G.M. van , Roozenbeek, Bob , Lingsma, Hester F. , Krisht, Ali F., Volovici, Victor , Verploegh, Iris S.C. , Lanzino, Giuseppe , Dammers, Rúben

Mayo Clinic

No container title available | February 16, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-228958/v1 Get It

Abstract Growth of unruptured intracranial aneurysms (UIAs) is a strong predictor of rupture. Clinical observations suggest that UIAs might grow faster after endovascular treatment than untreated UIAs. There are no head-to-head comparisons of incidence rates of UIAs so far. In this meta-analysis, we compared the incidence rates of growth of untreated UIAs and endovascularly treated UIAs. Methods: We searched PubMed, Embase and Google Scholar for relevant articles and conference abstracts in English, German or French from the inception of the databases to March 2020. We performed a meta-analysis by pooling the incidence rates for growth of aneurysms from natural history studies and endovascular treatment studies. Generalized linear models were used for multivariable adjustment for the prespecified confounders age, size and location. Results: 25 studies (10 describing growth in natural history and 15 reporting growth after endovascular therapy) with 6325 aneurysms were included in the meta-analysis. Median size of the aneurysm was 3.7 mm in the natural history studies and 6.4 mm in endovascular treatment studies (p = 0.001). The pooled incidence rate (IR) of growth was significantly higher in endovascular treatment studies (IR 52 per 1000 person-years, 95% Confidence Interval (CI) 36–79) compared to natural history studies (IR 28 per 1000 person-years, 95% CI 17–46), also after adjustment. Conclusion: The incidence rate of growth in endovascularly treated aneurysms was higher than in natural history studies. However, these results should be viewed in the light of high risk of bias of the individual studies and risk of ecological bias.
A comparison of 2 visual methods for classifying obstructive vs central hypopneas
Dupuy-McCauley, Kara , Mudrakola, Harsha V. , Colaco, Brendon, Arunthari, Vichaya, Slota, Katarzyna A., Morgenthaler, Timothy I.

Mayo Clinic

Journal of Clinical Sleep Medicine | February 16, 2021 | Volume: 17 | Issue: 6 | Pages: 1157-1165

10.5664/jcsm.9140 | PMID 33583493 Get It

D‐index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
Vijayvargiya, Prakhar , Abad, Cybéle Lara R. , Garrigos, Zerelda Esquer , O’Horo, John C. , Walker, Randall C., Tande, Aaron J. , Abad, Cybele L R , Esquer Garrigos, Zerelda , Tande, Aaron , O'Horo, John C , Hogan, William J.

Mayo Clinic

Transplant Infectious Disease | February 16, 2021 | Volume: 23 | Issue: 4 | Pages: No page available

10.1111/tid.13588 | PMID 33590904 Get It

AbstractBackgroundNeutropenia is a risk factor for development of infections; however, the direct effect of neutropenia on development of bloodstream infection (BSI) is not known. D‐index, which is area between the neutrophil time curve and a neutrophil count of 0.5 × 109/L, incorporates the combined effect of severity and duration of neutropenia. We aimed to evaluate whether D‐index can be used as a marker for BSI in patients with allogeneic stem cell transplantation.MethodWe conducted a retrospective cohort study of patients undergoing allogeneic stem cell transplantation between January 1, 2005, and September 30, 2015. The primary outcome measure was the development of BSI within 30 days of transplantation.ResultsA total of 714 patients were included in the study of whom 101 developed BSI. Patients with BSI had a significantly higher median D‐index value compared with patients who did not have BSI (4990 vs. 3570, P < .001). As a marker, the performance of the D‐index was similar to that of the duration of profound neutropenia (P = .18) and significantly better than the total duration of neutropenia (P = .001).ConclusionThe D‐index performed better than the total duration of neutropenia as a marker for BSI in patients with allogeneic stem cell transplantation. There was no difference between D‐index and, a more easily calculable indicator, duration of profound neutropenia.
Necrotizing Fasciitis: A True Breast Emergency
Bhatt, Asha A. , Khandelwal, Ashish

Mayo Clinic

Journal of Breast Imaging | February 16, 2021 | Volume: 3 | Issue: 3 | Pages: 403-404

10.1093/jbi/wbab004 Get It

High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Majumder, Shounak , Wu, Chung Wah, Bamlet, William R. , Burger, Kelli N. , Postier, Neil, Fuente, Jaime de la , Lidgard, Graham P. , Allawi, Hatim T. , Petersen, Gloria M. , Chari, Suresh T. , Ahlquist, David A. , Foote, Patrick H. , Berger, Calise K. , Mahoney, Douglas W. , Bamlet, William R , de la Fuente, Jaime , Doering, Karen A , Kisiel, John B , Majumder, Shounak , Chari, Suresh T , Taylor, William R. , Doering, Karen A. , Kisiel, John B.

Mayo Clinic

Clinical Cancer Research | February 16, 2021 | Volume: 27 | Issue: 9 | Pages: 2523-2532

10.1158/1078-0432.ccr-20-0235 | PMID 33593879 Get It

Abstract Purpose: We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case–control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. Experimental Design: Thirteen MDMs (GRIN2D, CD1D, ZNF781, FER1L4, RYR2, CLEC11A, AK055957, LRRC4, GH05J042948, HOXA1, PRKCB, SHISA9, and NTRK3) were identified on the basis of selection criteria applied to results of prior tissue experiments and assays were optimized in plasma. Next, 340 plasma samples (170 PDAC cases and 170 controls) were assayed using target enrichment long-probe quantitative amplified signal method. Initially, 120 advanced-stage PDAC cases and 120 healthy controls were used to train a prediction algorithm at 97.5% specificity using random forest modeling. Subsequently, the locked algorithm derived from the training set was applied to an independent blinded test set of 50 early-stage PDAC cases and 50 controls. Finally, data from all 340 patients were combined, and cross-validated. Results: The cross-validated area under the receiver operating characteristic curve (AUC) for the training set was 0.93 (0.89–0.96) for the MDM panel alone, 0.91 (95% confidence interval, 0.87–0.96) for carbohydrate antigen 19-9 (CA19-9) alone, and 0.99 (0.98–1) for the combined MDM-CA19-9 panel. In the test set of early-stage PDAC, the AUC for MDMs alone was 0.84 (0.76–0.92), CA19-9 alone was 0.87 (0.79–0.94), and combined MDM-CA19-9 panel was 0.90 (0.84–0.97) significantly better compared with either MDMs alone or CA19-9 alone (P = 0.0382 and 0.0490, respectively). At a preset specificity of 97.5%, the sensitivity for the combined panel in the test set was 80% (28%–99%) for stage I disease and 82% (68%–92%) for stage II disease. Using the combined datasets, the cross-validated AUC was 0.9 (0.86–0.94) for the MDM panel alone and 0.89 for CA19-9 alone (0.84–0.93) versus 0.97 (0.94–0.99) for the combined MDM-CA19-9 panel (P ≤ 0.0001). Overall, cross-validated sensitivity of MDM-CA19-9 panel was 92% (83%–98%), with an observed specificity of 92% at the preset specificity of 97.5%. Conclusions: Plasma MDMs in combination with CA19-9 detect PDAC with significantly higher accuracy compared with either biomarker individually.
The Increasing Proportion of Early-Stage Pancreatic Cancer between 2004–2013: A SEER Analysis
Oman, Sven P. , Corral, Juan E. , Stauffer, John , Mody, Kabir , Wallace, Michael B. , Raimondo, Massimo , Wallace, Michael B , A Stauffer, John

Mayo Clinic

Cancer Investigation | February 16, 2021 | Volume: 39 | Issue: 3 | Pages: 229-234

10.1080/07357907.2021.1888386 | PMID 33571039 Get It

Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters
Pai, Reetesh K. , Rosty, Christophe , Shivji, Sameer , Kirsch, Richard , Pai, Rish K. , Rosty, Christophe , Shivji, Sameer , Pai, R K , Hartman, Douglas J. , Schaeffer, David F.

Mayo Clinic

Histopathology | February 16, 2021 | Volume: 79 | Issue: 3 | Pages: 391-405

10.1111/his.14353 | PMID 33590485 Get It

AimsTo develop and validate a deep learning algorithm to quantify a broad spectrum of histological features in colorectal carcinoma.Methods and resultsA deep learning algorithm was trained on haematoxylin and eosin‐stained slides from tissue microarrays of colorectal carcinomas (N = 230) to segment colorectal carcinoma digitised images into 13 regions and one object. The segmentation algorithm demonstrated moderate to almost perfect agreement with interpretations by gastrointestinal pathologists, and was applied to an independent test cohort of digitised whole slides of colorectal carcinoma (N = 136). The algorithm correctly classified mucinous and high‐grade tumours, and identified significant differences between mismatch repair‐proficient and mismatch repair‐deficient (MMRD) tumours with regard to mucin, inflammatory stroma, and tumour‐infiltrating lymphocytes (TILs). A cutoff of >44.4 TILs per mm2 carcinoma gave a sensitivity of 88% and a specificity of 73% in classifying MMRD carcinomas. Algorithm measures of tumour budding (TB) and poorly differentiated clusters (PDCs) outperformed TB grade derived from routine sign‐out, and compared favourably with manual counts of TB/PDCs with regard to lymphatic, venous and perineural invasion. Comparable associations were seen between algorithm measures of TB/PDCs and manual counts of TB/PDCs for lymph node metastasis (all P < 0.001); however, stronger correlations were seen between the proportion of positive lymph nodes and algorithm measures of TB/PDCs. Stronger associations were also seen between distant metastasis and algorithm measures of TB/PDCs (P = 0.004) than between distant metastasis and TB (P = 0.04) and TB/PDC counts (P = 0.06).ConclusionsOur results highlight the potential of deep learning to identify and quantify a broad spectrum of histological features in colorectal carcinoma.